Skip to content

Opening book details…

About this Medicine article

Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial by Romera, Alvaro; Peredpaya, Sergiy; Shparyk, Yaroslav; Bondarenko, Igor; Mendonça Bariani, Giovanni; Abdalla, Kathia Cristina; Roca, Enrique; Franke, Fábio; Melo Cruz, Felipe; Ramesh, Anita; Ostwal, Vikas; Shah, Pradeep; Rahuman, Sajeed Abdul; Paravisini, Alexandra; Huerga, Camino; Del Campo García, Ana; Millán, Susana is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Romera, Alvaro; Peredpaya, Sergiy; Shparyk, Yaroslav; Bondarenko, Igor; Mendonça Bariani, Giovanni; Abdalla, Kathia Cristina; Roca, Enrique; Franke, Fábio; Melo Cruz, Felipe; Ramesh, Anita; Ostwal, Vikas; Shah, Pradeep; Rahuman, Sajeed Abdul; Paravisini, Alexandra; Huerga, Camino; Del Campo García, Ana; Millán, Susana
Publisher
Elsevier ; Elsevier Limited; Elsevier BV (ISSN 2468-1253)
Published
2018
Field
Medicine (Health Sciences)

More by Romera, Alvaro; Peredpaya, Sergiy; Shparyk, Yaroslav; Bondarenko, Igor; Mendonça Bariani, Giovanni; Abdalla, Kathia Cristina; Roca, Enrique; Franke, Fábio; Melo Cruz, Felipe; Ramesh, Anita; Ostwal, Vikas; Shah, Pradeep; Rahuman, Sajeed Abdul; Paravisini, Alexandra; Huerga, Camino; Del Campo García, Ana; Millán, Susana

Browse all works by Romera, Alvaro; Peredpaya, Sergiy; Shparyk, Yaroslav; Bondarenko, Igor; Mendonça Bariani, Giovanni; Abdalla, Kathia Cristina; Roca, Enrique; Franke, Fábio; Melo Cruz, Felipe; Ramesh, Anita; Ostwal, Vikas; Shah, Pradeep; Rahuman, Sajeed Abdul; Paravisini, Alexandra; Huerga, Camino; Del Campo García, Ana; Millán, Susana